Could symptom overlap of COVID-19 and Guillain-Barré syndrome mask an epidemiological association?

Svacina, Martin K R; Kohle, Felix; Sprenger, Alina; Lehmann, Helmar C

Svacina, Martin K R; Kohle, Felix; Sprenger, Alina; Lehmann, Helmar C.

Svacina MKR; Department of Neurology, Faculty of Medicine, University Hospital of Cologne, Kerpener Straße 62, 50937, Köln, Germany.
Kohle F; Department of Neurology, Faculty of Medicine, University Hospital of Cologne, Kerpener Straße 62, 50937, Köln, Germany.
Sprenger A; Department of Neurology, Faculty of Medicine, University Hospital of Cologne, Kerpener Straße 62, 50937, Köln, Germany.
Lehmann HC; Department of Neurology, Faculty of Medicine, University Hospital of Cologne, Kerpener Straße 62, 50937, Köln, Germany. helmar.lehmann@uk-koeln.de.

J Neurol ; 268(10): 3595-3597, 2021 Oct.

Article in English | MEDLINE | ID: covidwho-1439721

Subject(s)

COVID-19; Guillain-Barre Syndrome; Guillain-Barre Syndrome/epidemiology; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: J Neurol Year: 2021 Document Type: Article Affiliation country: S00415-021-10515-8

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google